跳至主要内容
临床试验/EUCTR2016-000481-32-IT
EUCTR2016-000481-32-IT进行中(未招募)1 期

TERIPARATIDE FOR THE PRIMARY PREVENTION OF POST-SURGICAL HYPOCALCEMIA - THYPOS

IVERSITÀ CAMPUS BIO-MEDICO DI ROMA0 个研究点目标入组 26 人开始时间: 2021年6月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • surgical indication for thyroidectomy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 16
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • -Age younger than 18 years
  • -Pregnancy
  • -Renal failure (glomerular filtration rate < 30 mL/min)
  • -Hypersensitivity to the active substance or excipients
  • -Any prior parathyroid pathology
  • -Familiar history of Osteosarcoma or any other bone tumors
  • -Preexisting hypercalcemia
  • -Symptomatic orthostatic hypotension
  • -Metabolic bone disease other than osteoporosis
  • -Ongoing teriparatide therapy for osteoporosis
  • -History of skeletal malignancies (primary or metastatic)
  • -Treatment with digoxin (digitalis therapy)
  • -Active or recent urolithiasis
  • -Unexplained elevation of serum alkaline phosphatase levels
  • -Prior radiation therapy involving the skeleton

研究者

发起方
IVERSITÀ CAMPUS BIO-MEDICO DI ROMA

相似试验